Experts raise concerns that DNA fragments in the vaccines could overstimulate the immune system, potentially increasing cancer risk.
A peer-reviewed study published in the *Journal of High School Science* reveals that Pfizer’s mRNA COVID-19 vaccines contain residual DNA exceeding regulatory safety limits.
The research was conducted by student scientists at the FDA’s White Oak Campus lab in Maryland.
Residual DNA, leftover genetic material from the manufacturing process, was found in levels exceeding the WHO guideline of 10 nanograms per dose by six to 470 times.
Researchers analyzed vaccines from BEI Resources, using NanoDrop and Qubit methods to detect DNA levels above acceptable thresholds in six vials from two vaccine lots.
While the study acknowledges currently unknown health risks, researchers theorize that the DNA fragments could integrate into human DNA, potentially causing gene mutations and increasing cancer risk due to the presence of oncogenes. Further testing is recommended.
The FDA has yet to comment on the findings, despite past reports of DNA contamination in COVID-19 vaccines being dismissed.
Kevin McKernan of Medicinal Genomics called the study a “bombshell,” suggesting that the DNA fragments might overstimulate the immune system, potentially promoting cancer growth, particularly with repeated booster shots.
“Repeated exposure to foreign DNA through Covid-19 boosters may amplify this risk over time, creating conditions conducive to cancer development,” McKernan stated in an interview with Maryanne Demasi.
Nikolai Petrovsky of Vaxine termed the findings a “smoking gun” requiring urgent regulatory attention, accusing the FDA of withholding information given the study’s origin within their own lab.